c-Met is a chimeric antigen receptor T-cell target for treating recurrent nasopharyngeal carcinoma

Autor: Huo, Qingyi, Lv, Jiang, Zhang, Jianzhong, Huang, Haiqiong, Hu, Huayong, Zhao, Yaoxin, Zhang, Xinrui, Wang, Yingqi, Zhou, Yiyi, Qiu, Junchao, Ye, Yanmei, Huang, Aiqun, Chen, Yanhong, Qin, Le, Qin, Dajiang, Li, Peng, Cai, Gang
Zdroj: In Cytotherapy June 2023
Databáze: ScienceDirect